LENSAR, Inc. (LNSR)
USD 13.69
(-2.63%)
USD 13.69
(-2.63%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 22.4 Million USD | 61.68% |
| 2022 | 13.86 Million USD | 19.63% |
| 2021 | 11.58 Million USD | -2.72% |
| 2020 | 11.91 Million USD | -81.7% |
| 2019 | 65.08 Million USD | 31.89% |
| 2018 | 49.35 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 23.97 Million USD | 16.67% |
| 2024 Q1 | 20.55 Million USD | -8.29% |
| 2023 Q1 | 12.52 Million USD | -9.65% |
| 2023 FY | 22.4 Million USD | 61.68% |
| 2023 Q4 | 22.4 Million USD | -34.99% |
| 2023 Q3 | 34.47 Million USD | -10.48% |
| 2023 Q2 | 38.5 Million USD | 207.48% |
| 2022 Q3 | 12.21 Million USD | -11.45% |
| 2022 Q2 | 13.79 Million USD | 31.57% |
| 2022 Q1 | 10.48 Million USD | -9.49% |
| 2022 FY | 13.86 Million USD | 19.63% |
| 2022 Q4 | 13.86 Million USD | 13.44% |
| 2021 Q1 | 9.21 Million USD | -22.64% |
| 2021 FY | 11.58 Million USD | -2.72% |
| 2021 Q4 | 11.58 Million USD | 4.8% |
| 2021 Q3 | 11.05 Million USD | 1.83% |
| 2021 Q2 | 10.85 Million USD | 17.82% |
| 2020 Q4 | 11.91 Million USD | 1.24% |
| 2020 Q2 | 74.29 Million USD | 0.0% |
| 2020 Q3 | 11.76 Million USD | -84.17% |
| 2020 Q1 | - USD | -100.0% |
| 2020 FY | 11.91 Million USD | -81.7% |
| 2019 Q4 | 65.08 Million USD | 0.0% |
| 2019 FY | 65.08 Million USD | 31.89% |
| 2019 Q1 | - USD | 0.0% |
| 2018 FY | 49.35 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 56.279% |
| BrainsWay Ltd. | 15.31 Million USD | -46.33% |
| Cerus Corporation | 144.3 Million USD | 84.471% |
| Envoy Medical, Inc. | 9.4 Million USD | -138.343% |
| electroCore, Inc. | 8.94 Million USD | -150.52% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -319.487% |
| IceCure Medical Ltd | 4.24 Million USD | -427.643% |
| Inogen, Inc. | 121.38 Million USD | 81.538% |
| OrthoPediatrics Corp. | 72.56 Million USD | 69.117% |
| Lucid Diagnostics Inc. | 29.58 Million USD | 24.245% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -604.255% |
| MaxCyte, Inc. | 36.1 Million USD | 37.937% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -1112.667% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -5169.222% |
| Orthofix Medical Inc. | 326.58 Million USD | 93.138% |
| PAVmed Inc | 57.13 Million USD | 60.78% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | 11.994% |
| RxSight, Inc. | 22.18 Million USD | -0.996% |
| Sight Sciences, Inc. | 46.43 Million USD | 51.742% |
| SI-BONE, Inc. | 61.05 Million USD | 63.294% |
| TELA Bio, Inc. | 59.16 Million USD | 62.126% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 80.338% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -117.163% |
| Acutus Medical, Inc. | 54.83 Million USD | 59.137% |
| Talis Biomedical Corporation | 29.22 Million USD | 23.32% |
| Spectral AI, Inc. | 12.4 Million USD | -80.703% |
| Nano-X Imaging Ltd. | 23.13 Million USD | 3.134% |
| CVRx, Inc. | 39.28 Million USD | 42.954% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -87.396% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -822.447% |
| Bioventus Inc. | 589.79 Million USD | 96.201% |
| Venus Concept Inc. | 107.1 Million USD | 79.077% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 56.625% |
| LivaNova PLC | 1.15 Billion USD | 98.055% |
| 908 Devices Inc. | 37.49 Million USD | 40.227% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 96.815% |
| Nemaura Medical Inc. | 26.37 Million USD | 15.045% |
| NeuroPace, Inc. | 86.99 Million USD | 74.242% |
| Apyx Medical Corporation | 52.31 Million USD | 57.168% |
| Cutera, Inc. | 518.12 Million USD | 95.675% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | 23.592% |
| BioSig Technologies, Inc. | 4.68 Million USD | -378.314% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 61.607% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -4.286% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 98.979% |
| Axonics, Inc. | 82.35 Million USD | 72.791% |
| Outset Medical, Inc. | 190.91 Million USD | 88.262% |
| IRIDEX Corporation | 24.91 Million USD | 10.055% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 81.923% |
| IRadimed Corporation | 20.73 Million USD | -8.068% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -1238.65% |
| INVO Bioscience, Inc. | 19.99 Million USD | -12.073% |
| Telesis Bio, Inc. | 40.87 Million USD | 45.174% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 45.063% |
| Varex Imaging Corporation | 668.6 Million USD | 96.648% |
| Quipt Home Medical Corp. | 136.29 Million USD | 83.558% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -527.352% |
| Pulmonx Corporation | 60.63 Million USD | 63.043% |
| Dynatronics Corporation | 11.78 Million USD | -90.227% |
| Modular Medical, Inc. | 2.27 Million USD | -886.312% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -451.403% |
| Semler Scientific, Inc. | 6.27 Million USD | -257.4% |
| InMode Ltd. | 75.91 Million USD | 70.481% |
| Bruker Corporation | 2.83 Billion USD | 99.21% |
| Cytosorbents Corporation | 29.98 Million USD | 25.267% |
| DexCom, Inc. | 4.19 Billion USD | 99.466% |
| Align Technology, Inc. | 2.45 Billion USD | 99.087% |
| Viveve Medical, Inc. | 10.84 Million USD | -106.592% |
| ZimVie Inc. | 795.85 Million USD | 97.184% |
| Movano Inc. | 5.97 Million USD | -275.234% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 78.578% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -5169.222% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -87.396% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 96.493% |
| Profound Medical Corp. | 12.66 Million USD | -76.924% |
| Insulet Corporation | 1.85 Billion USD | 98.792% |
| enVVeno Medical Corporation | 2.43 Million USD | -820.287% |
| Surmodics, Inc. | 65.82 Million USD | 65.956% |
| iCAD, Inc. | 8 Million USD | -180.078% |
| Nuwellis, Inc. | 6.78 Million USD | -230.516% |
| Biotricity, Inc. | 35.91 Million USD | 37.613% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 89.953% |
| Aethlon Medical, Inc. | 2.47 Million USD | -803.716% |
| InspireMD, Inc. | 8.14 Million USD | -175.227% |
| PAVmed Inc. | 57.13 Million USD | 60.78% |
| BIOLASE, Inc. | 35.34 Million USD | 36.605% |
| Beyond Air, Inc. | 29.77 Million USD | 24.739% |
| FONAR Corporation | 57.45 Million USD | 60.999% |
| AxoGen, Inc. | 101.16 Million USD | 77.848% |
| Vivani Medical, Inc. | 25.03 Million USD | 10.493% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 74.476% |
| Inari Medical, Inc. | 209.32 Million USD | 89.295% |
| UFP Technologies, Inc. | 118.04 Million USD | 81.017% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -76.581% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -925.203% |
| Tenon Medical, Inc. | 5.56 Million USD | -302.533% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -1159.64% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -27.078% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.289% |
| Sintx Technologies, Inc. | 6.59 Million USD | -239.891% |
| NanoVibronix, Inc. | 2.68 Million USD | -734.289% |
| Quanterix Corporation | 78.08 Million USD | 71.301% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -527.352% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -358.731% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 97.855% |
| TransMedics Group, Inc. | 568.84 Million USD | 96.061% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -34.33% |
| NeuroMetrix, Inc. | 1.33 Million USD | -1580.939% |
| Hyperfine, Inc. | 9.8 Million USD | -128.663% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 91.045% |
| Biomerica, Inc. | 2.66 Million USD | -741.495% |
| Bone Biologics Corporation | 831.4 Thousand USD | -2595.327% |
| AVITA Medical, Inc. | 19.86 Million USD | -12.804% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -1035.39% |
| Silk Road Medical, Inc | 114.15 Million USD | 80.37% |